About the Authors
- Daniel Paris
-
* E-mail: dparis@rfdn.org
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- David Beaulieu-Abdelahad
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Myles Mullan
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Ghania Ait-Ghezala
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Venkat Mathura
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Corbin Bachmeier
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Fiona Crawford
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
- Michael J. Mullan
-
Affiliation Roskamp Institute, Sarasota, Florida, United States of America
Competing Interests
Anatabine was supplied for this research by Rock Creek Pharmaceuticals who sell anatabine as a food supplement. Rock Creek Pharmaceuticals also partially funded this study. The Roskamp Institute is a not-for-profit public charity and none of its staff (who comprise all the authors on this paper) receive remuneration from Rock Creek Pharmaceuticals. There are no other potential conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DP MJM. Performed the experiments: DP DB MM GA VM CB FC. Analyzed the data: DP MJM. Contributed reagents/materials/analysis tools: VM FC. Wrote the paper: DP MJM.